S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:AUVI

Applied UV Stock Forecast, Price & News

$9.17
+1.37 (+17.56 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.35
Now: $9.17
$9.82
50-Day Range
$4.85
MA: $8.14
$19.71
52-Week Range
$4.52
Now: $9.17
$35.78
Volume2.03 million shs
Average Volume3.56 million shs
Market Capitalization$72.86 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Applied UV, Inc. engages in the design, manufacture, assembly, and distribution of automated disinfecting mirror systems for use in hospitals and other healthcare facilities. The company also manufactures and supplies custom designed decorative framed mirrors, framed arts, and bathroom vanities primarily to the hospitality market. It has operations in the United States and internationally. Applied UV, Inc. was founded in 2012 and is headquartered in Mount Vernon, New York.

Headlines

Why Applied UV Is Trading Higher Today
February 9, 2021 |  benzinga.com
Applied UV Inc.
December 18, 2020 |  barrons.com
See More Headlines

Industry, Sector and Symbol

Industry Electric lighting & wiring equipment
Sub-IndustryN/A
Current SymbolNASDAQ:AUVI
CUSIPN/A
CIKN/A
Phone929-207-3751
Employees26
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$72.86 million
Next Earnings Date3/8/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.50 out of 5 stars

Business Services Sector

340th out of 442 stocks

Electric Lighting & Wiring Equipment Industry

12th out of 13 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$9.17
+1.37 (+17.56 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AUVI News and Ratings via Email

Sign-up to receive the latest news and ratings for AUVI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Applied UV (NASDAQ:AUVI) Frequently Asked Questions

Is Applied UV a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied UV in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Applied UV stock.
View analyst ratings for Applied UV
or view top-rated stocks.

What stocks does MarketBeat like better than Applied UV?

Wall Street analysts have given Applied UV a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Applied UV wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Applied UV?

Applied UV saw a increase in short interest in February. As of February 12th, there was short interest totaling 398,700 shares, an increase of 203.0% from the January 28th total of 131,600 shares. Based on an average trading volume of 2,290,000 shares, the days-to-cover ratio is currently 0.2 days. Approximately 14.7% of the shares of the company are sold short.
View Applied UV's Short Interest
.

When is Applied UV's next earnings date?

Applied UV is scheduled to release its next quarterly earnings announcement on Monday, March 8th 2021.
View our earnings forecast for Applied UV
.

Who are Applied UV's key executives?

Applied UV's management team includes the following people:
  • Mr. Max Munn, Pres & Director (Age 76, Pay $400k)
  • Mr. Keyoumars Saeed, CEO & Director (Age 57)
  • Mr. Joseph N. Himy, Interim Chief Financial Officer (Age 51)
  • Mr. James L. Doyle III, Chief Operations Officer (Age 53)
  • Mr. Robert Berger, Vice-Pres Global Sales
  • Ms. Rhonda A. Wallen, VP of Product Marketing & Corp. Devel. (Age 54)

Who are some of Applied UV's key competitors?

When did Applied UV IPO?

(AUVI) raised $5 million in an IPO on the week of August 31st 2020. The company issued 1,000,000 shares at a price of $5.00 per share. Network 1 Financial Securities, Inc. acted as the underwriter for the IPO and Dawson James Securities was co-manager.

What is Applied UV's stock symbol?

Applied UV trades on the NASDAQ under the ticker symbol "AUVI."

When did the company's lock-up period expire?

Applied UV's lock-up period expired on Monday, March 1st. Applied UV had issued 1,000,000 shares in its IPO on August 31st. The total size of the offering was $5,000,000 based on an initial share price of $5.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the expiration of the lock-up period.

Who are Applied UV's major shareholders?

Applied UV's stock is owned by many different institutional and retail investors. Top institutional investors include Walleye Capital LLC (0.73%).

Which major investors are buying Applied UV stock?

AUVI stock was bought by a variety of institutional investors in the last quarter, including Walleye Capital LLC.

How do I buy shares of Applied UV?

Shares of AUVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied UV's stock price today?

One share of AUVI stock can currently be purchased for approximately $9.17.

How much money does Applied UV make?

Applied UV has a market capitalization of $72.86 million.

How many employees does Applied UV have?

Applied UV employs 26 workers across the globe.

What is Applied UV's official website?

The official website for Applied UV is www.applieduvinc.com.

Where are Applied UV's headquarters?

Applied UV is headquartered at 150 N. MACQUESTEN PKWY, MOUNT VERNON NY, 10550.

How can I contact Applied UV?

Applied UV's mailing address is 150 N. MACQUESTEN PKWY, MOUNT VERNON NY, 10550. The company can be reached via phone at 929-207-3751 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.